A biological pharmacology network to secure the risk of drug-drug interaction with nirmatrelvir/ritonavir.
Lemaitre F, Boland L, Tron C, Grégoire M, Lelong-Boulouard V, Gandia P, Goirand F, Gambier N, Boglione-Kerrien C, Franck B, Lalanne S, Devresse A, Briol S, Haufroid V, Verdier MC; SFPT Therapeutic Drug Monitoring, Treatment Personalization group (STP-PT) of the French Society of Pharmacology, Therapeutics (SFPT).
Lemaitre F, et al.
Therapie. 2024 Jul 26:S0040-5957(24)00081-7. doi: 10.1016/j.therap.2024.07.003. Online ahead of print.
Therapie. 2024.
PMID: 39174455
In this study, we aimed at describing the expert advices provided by the biological pharmacology network of the SFPT (i.e., the therapeutic drug monitoring specialists working in the laboratories of the pharmacology departments in France/Belgium). From February to A …
In this study, we aimed at describing the expert advices provided by the biological pharmacology network of the SFPT (i.e., the thera …